MedPath

AZIENDA SOCIO SANITARIA TERRITORIALE DI MANTOVA

🇮🇹Italy
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:1

Trial Phases

2 Phases

Phase 2:1
Phase 3:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 2
1 (50.0%)
Phase 3
1 (50.0%)

Convalescent Plasma in Hospitalized COVID-19 Patients

Conditions
COVID-19
First Posted Date
2021-12-14
Last Posted Date
2023-07-21
Lead Sponsor
Azienda Socio Sanitaria Territoriale di Mantova
Registration Number
NCT05157165

Convalescent Plasma in COVID-19 Elderly Patients

Phase 2
Completed
Conditions
COVID-19
First Posted Date
2020-09-29
Last Posted Date
2020-10-05
Lead Sponsor
Azienda Socio Sanitaria Territoriale di Mantova
Target Recruit Count
21
Registration Number
NCT04569188
Locations
🇮🇹

Transfusion Service, Mantova, Italy

Intravenous Immunoglobulin for Unverricht-Lundborg Disease.

Phase 3
Conditions
Unverricht-Lundborg Disease
Interventions
First Posted Date
2017-11-24
Last Posted Date
2017-11-27
Lead Sponsor
Azienda Socio Sanitaria Territoriale di Mantova
Target Recruit Count
1
Registration Number
NCT03351569

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.